SEO URLwww.firestrike.ai/deals/rapt-therapeutics-gsk-acquisition-2026-10

acquisitionAnnounced · Jan 20, 2026life sciencesSource · CredibleArticle · Factual

RAPT Therapeutics · GSK

GSK acquires RAPT Therapeutics

David Najork · Founding Software Engineer

Announced Jan 20, 2026 · Updated Apr 29, 2026 · 1 min read

ShareX LinkedIn Email

Deal value

$2.2B

Target

RAPT Therapeutics

NASDAQ: RAPT · South San Francisco, California

Acquirer

GSK

Full Acquisition

Status

Announced

GSK agreed to acquire RAPT Therapeutics. Reported deal value: $2.2B. Status: Announced. Sector: life sciences. Target headquarters context: South San Francisco, California, United States.

This page summarizes publicly available information about the transaction as of 2026-01-20. Figures and status may change as filings and press coverage update.

Deal timeline

Announced

Jan 20, 2026 · manilatimes.net

Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.

Sector context

This transaction is classified in life sciences with a reported deal value of $2.2B. Figures and status may change as sources update.

Sources: manilatimes.net · Primary article · FireStrike proprietary index